22nd Century Group Inc (NYSEMKT:XXII) Leads The Market By Producing Zero THC Industrial Hemp At Anandia Labs

0
390

22nd Century Group Inc (NYSEMKT:XXII) which happens to be a high end plant biotechnology company specializing on tobacco harm reduction and cannabis research today came forward to make the announcement regarding its collaboration with a worthy partner, Anandia Laboratories, Inc.

The partnership according to sources close to the company will go a long way towards promoting industrial hemp plants bearing zero tetrahydrocannabinol which is a central psychoactive constituent in cannabis.

Cannabis sativa over the years has been used as a source of fiber, medicine and above all as a recreational psychoactive drug. The Drug type cannabis is fundamentally to serve medical needs and at the same time is used for recreation purposes. It is known to contain quite high levels of THC and some of the experts refer to it as a Schedule 1 narcotic.

The main challenge the industrial hemp industry has struggled with over the years is trying to eliminate THC in industrial hemp. Most of the hemp crops are subjected to a test that seeks out identifying the THC levels. In efforts to drive the company’s growth to higher levels with its THC-free hemp, it is accumulating experience and learning important lessons all the same.

22nd Century’s Vice President for Plant Biotechnology, Dr. Paul Rushton expressed the company’s anticipation. He made it clear that the company looks forward to continue dealing in its zero THC hemp plants. The President and CEO of Anandia Labs, Jonathan Page showed his delight in the fact that their initial project with 22nd Century-one of the Best Biotech Stocks, had grown to become a huge success.

The new and exciting results will go a long way towards the development of hemp varieties that minimize the significant regulatory challenges around THC in the United States and of course positioning 22nd Century as a giant in high quality hemp production.

A lot is going on in the company in terms of laying down strategies to help uplift the company to levels of the top Biotech Stocks. There are high chances that the company will succeed provided it continues with the resilience it has been showcasing lately.

LEAVE A REPLY

Please enter your comment!
Please enter your name here